5-Lipoxygenase is involved in the angiotensin II-induced NAD(P)H-oxidase activation

Biochemical and Biophysical Research Communications

Volumn 308, Issue 3, 2003, Pages 668-672

  Luchtefeld, Maren ^a   Drexler, Helmut ^a   Schieffer, Bernhard ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

5 Lipoxygenase; Angiotensin II; Leukotriene B4; NAD(P)H oxidase

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; ANGIOTENSIN; ARACHIDONATE 5 LIPOXYGENASE; DIPHENYLENEIODONIUM CHLORIDE; DIPHENYLIODONIUM SALT; INTERLEUKIN 6; LEUKOTRIENE B4; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG;

ANIMAL CELL; AORTA; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RAT; SMOOTH MUSCLE FIBER;

EID: 0043166931     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)01456-6     Document Type: Article

References (25)

1. Irani K. Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ. Res. 87:2000;179-183.
2. Griendling K.K., Sorescu D., Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86:2000;494-501.
3. Shiose A., Sumimoto H. Arachidonic acid and phosphorylation synergistically induce a conformational change of p47phox to activate the phagocyte NADPH oxidase. J. Biol. Chem. 275:2000;13793-13801.
4. Zafari A.M., Ushio-Fukai M., Minieri C.A., Akers M., Lassegue B., Griendling K.K. Arachidonic acid metabolites mediate angiotensin II-induced NADH/NADPH oxidase activity and hypertrophy in vascular smooth muscle cells. Antioxid. Redox Signal. 1:1999;167-179.
5. Dewald B., Baggiolini M. Activation of NADPH oxidase in human neutrophils. Synergism between fMLP and the neutrophil products PAF and LTB4. Biochem. Biophys. Res. Commun. 128:1985;297-304.
6. Woo C.H., Eom Y.W., Yoo M.H., You H.J., Han H.J., Song W.K., Yoo Y.J., Chun J.S., Kim J.H. Tumor necrosis factor-alpha generates reactive oxygen species via a cytosolic phospholipase A2-linked cascade. J. Biol. Chem. 275:2000;32357-32362.
7. Bae Y.S., Sung J.Y., Kim O.S., Kim Y.J., Hur K.C., Kazlauskas A., Rhee S.G. Platelet-derived growth factor-induced H(2)O(2) production requires the activation of phosphatidylinositol 3-kinase. J. Biol. Chem. 275:2000;10527-10531.
8. Woo C.H., Lee Z.W., Kim B.C., Ha K.S., Kim J.H. Involvement of cytosolic phospholipase A2, and the subsequent release of arachidonic acid, in signalling by rac for the generation of intracellular reactive oxygen species in rat-2 fibroblasts. Biochem. J. 348:2000;525-530.
9. Kim B.D., Kim J.H. Nuclear signalling by rac GTPase: essential role of phospholipase A2. Biochem. J. 326:1997;333-337.
10. Freeman E.J., Ruehr M.L., Dorman R.V. ANG II-induced translocation of cytosolic PLA2 to the nucleus in vascular smooth muscle cells. Am. J. Physiol. 274:1998;C282-288.
11. Silfani T.N., Freeman E.J. Phosphatidylinositide 3-kinase regulates angiotensin II-induced cytosolic phospholipase A2 activity and growth in vascular smooth muscle cells. Arch. Biochem. Biophys. 402:2002;84-93.
12. Rouzer C.A., Ford-Hutchinson A.W., Morton H.E., Gillard J.W. MK886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes. J. Biol. Chem. 265:1990;1436-1442.
13. Travo P., Barrett G., Burnstock G. Differences in proliferation of primary cultures of vascular smooth muscle cells taken from male and female rats. Blood Vessels. 17:1980;110-116.
14. Schieffer B., Luchtefeld M., Braun S., Hilfiker A., Hilfiker-Kleiner D., Drexler H. Role of NAD(P)H oxidase in angiotensin II-induced JAK/STAT signaling and cytokine induction. Circ. Res. 87:2000;1195-1201.
15. Ciapetti G., Granchi D., Verri E., Savarino L., Cenni E., Savioli F., Pizzoferrato A. Fluorescent microplate assay for respiratory burst of PMNs challenged in vitro with orthopedic metals. J. Biomed. Mater. Res. 41:1998;455-460.
16. ′ -dichlorofluorescin-diacetate J. Immunol. Methods. 156:1992;39-45.
17. Schieffer B., Wagner M., Hilfiker-Kleinert D., Hilfiker A., Drexler H. Circulation suppl. II. 1999;433.
18. Jendraschak E., Kaminski W.E., Kiefl R., von Schacky C. The human leukotriene A4 hydrolase gene is expressed in two alternatively spliced mRNA forms. Biochem. J. 314:1996;733-737.
19. Samuelsson B., Funk C.D. Enzymes involved in the biosynthesis of leukotriene B4. J. Biol. Chem. 264:1989;19469-19472.
20. Griendling K.K., Minieri C.A., Ollerenshaw J.D., Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 74:1994;1141-1148.
21. Samuelsson B., Dahlen S.E., Lindgren J.A., Rouzer C.A., Serhan C.N. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science. 237:1987;1171-1176.
22. Shimizu T., Radmark O., Samuelsson B. Enzyme with dual lipoxygenase activities catalyzes leukotriene A4 synthesis from arachidonic acid. Proc. Natl. Acad. Sci. USA. 81:1984;689-693.
23. Stankova J., Rola-Pleszczynski M. PAF and leukotrienes in inflammation. Mod. Asp. Immunobiol. 1:2001;244-248.
24. Abid M.R.K., Fan C., Yabe-Nishimura C. NADPH oxidase is involved in prostaglandin F2alpha-induced hypertrophy of vascular smooth muscle cells: induction of NOX1 by PGF2alpha. J. Biol. Chem. 6:2002;6.
25. Seshiah P.N., Weber D.S., Rocic P., Valppu L., Taniyama Y., Griendling K.K. Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ. Res. 91:2002;406-413.